Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  518 results for ""INFLIXIMAB""

Your Filters

Geographic : europe
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Collaborative study for the establishment of Infliximab Biological Reference Preparation Batch 1.

  • Authors : Wadhwa M; National Institute for Biological Standards and Control (NIBSC), Blanche Lane, South Mimms, Potters Bar, EN6 3QG, UK.; Rigsby P

Subjects: Infliximab* ; International Cooperation* ; World Health Organization*

  • Source: Pharmeuropa bio & scientific notes [Pharmeur Bio Sci Notes] 2020; Vol. 2020, pp. 49-52.Publisher: European Directorate for the Quality of Medicines Country of Publication: France NLM ID: 101510163 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Five-year Safety Data From OPUS, a European Observational Safety Registry for Adults With Ulcerative Colitis Treated With Originator Infliximab [Remicade®] or Conventional Therapy.

  • Authors : Panés J; Department of Gastroenterology, Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.; Lindsay JO

Subjects: Colitis, Ulcerative/Colitis, Ulcerative/Colitis, Ulcerative/*drug therapy ; Gastrointestinal Agents/Gastrointestinal Agents/Gastrointestinal Agents/*therapeutic use ; Infliximab/Infliximab/Infliximab/*therapeutic use

  • Source: Journal of Crohn's & colitis [J Crohns Colitis] 2019 Sep 19; Vol. 13 (9), pp. 1148-1157.Publisher: Oxford University Press Country of Publication: England NLM ID: 101318676 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Valuing Treatment With Infliximab for Ankylosing Spondylitis Using a Willingness-to-Pay Approach.

  • Authors : Webers C; Maastricht University Medical Center and School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, The Netherlands.; Essers I

Subjects: Drug Costs* ; Health Expenditures* ; Patient Acceptance of Health Care*

  • Source: Arthritis care & research [Arthritis Care Res (Hoboken)] 2018 Apr; Vol. 70 (4), pp. 608-616. Date of Electronic Publication: 2018 Feb 18.Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101518086 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The Continental Divide: Anti-TNF Use in Pediatric IBD Is Different in North America Compared to Other Parts of the World.

  • Authors : Church PC; Division of Gastroenterology, Hepatology & Nutrition, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Toronto, Canada.; Hyams J

Subjects: Adalimumab/Adalimumab/Adalimumab/*therapeutic use ; Colitis, Ulcerative/Colitis, Ulcerative/Colitis, Ulcerative/*drug therapy ; Crohn Disease/Crohn Disease/Crohn Disease/*drug therapy

  • Source: Canadian journal of gastroenterology & hepatology [Can J Gastroenterol Hepatol] 2018 Jun 12; Vol. 2018, pp. 3190548. Date of Electronic Publication: 2018 Jun 12 (Print Publisher: Hindawi Publishing Corporation Country of Publication: Egypt NLM ID: 101623613 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Comparison of the pharmacokinetics and safety of three formulations of infliximab (CT-P13, EU-approved reference infliximab and the US-licensed reference infliximab) in healthy subjects: a randomized, double-blind, three-arm, parallel-group, single-dose, Phase I study.

  • Authors : Park W; a 1 Inha University Hospital, Incheon, Republic of Korea.; Lee SJ

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*pharmacokinetics ; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*pharmacokinetics ; Biosimilar Pharmaceuticals/Biosimilar Pharmaceuticals/Biosimilar Pharmaceuticals/*pharmacokinetics

  • Source: Expert review of clinical immunology [Expert Rev Clin Immunol] 2015; Vol. 11 Suppl 1, pp. S25-31.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101271248 Publication Model: Print Cited Medium: Internet ISSN: 1744-8409

Record details

Read More Add to Saved list
×
Academic Journal

Subcutaneously-Administered Infliximab in the Management of Rheumatoid Arthritis: A Short Narrative Review of Current Clinical Evidence.

Subjects: RHEUMATOID arthritis; CROHN'S disease; MEDICAL personnelEUROPE

  • Source: Journal of Inflammation Research; Jun2022, Vol. 15, p3259-3267, 9p

Record details

Read More Add to Saved list
×
Academic Journal

Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe.

  • Authors : Armuzzi A; IBD Unit, Presidio Columbus Fondazione Policlinico A. Gemelli IRCCS-Università Cattolica del Sacro Cuore, Rome, Italy.; DiBonaventura MD

Subjects: Adalimumab/Adalimumab/Adalimumab/*therapeutic use ; Colitis, Ulcerative/Colitis, Ulcerative/Colitis, Ulcerative/*drug therapy ; Gastrointestinal Agents/Gastrointestinal Agents/Gastrointestinal Agents/*therapeutic use

  • Source: PloS one [PLoS One] 2020 Jan 16; Vol. 15 (1), pp. e0227914. Date of Electronic Publication: 2020 Jan 16 (Print Publication: 2020).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Long-term Outcomes of Paediatric Patients Admitted With Acute Severe Colitis- A Multicentre Study From the Paediatric IBD Porto Group of ESPGHAN.

  • Authors : Krauthammer A; Pediatric Gastroenterology Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Centre, Tel Hashomer, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Subjects: Colectomy*/Colectomy*/Colectomy*/adverse effects ; Colectomy*/Colectomy*/Colectomy*/methods ; Colectomy*/Colectomy*/Colectomy*/statistics & numerical data Pediatric ulcerative colitis

  • Source: Journal of Crohn's & colitis [J Crohns Colitis] 2019 Dec 10; Vol. 13 (12), pp. 1518-1526.Publisher: Oxford University Press Country of Publication: England NLM ID: 101318676 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Individual and Institutional Corruption in European and US Healthcare: Overview and Link of Various Corruption Typologies.

Subjects: Drug Substitution* ; Health Policy*; Biosimilar Pharmaceuticals/Biosimilar Pharmaceuticals/Biosimilar Pharmaceuticals/*administration & dosage

  • Source: Applied health economics and health policy [Appl Health Econ Health Policy] 2018 Jun; Vol. 16 (3), pp. 289-302.Publisher: Open Mind Journals Ltd Country of Publication: New Zealand NLM ID: 101150314 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis.

Subjects: ANALYSIS of variance; BIOLOGICAL products; BLOOD testingEUROPE

  • Source: Rheumatology; Aug2011, Vol. 50 Issue 8, p1445-1452, 8p, 1 Chart, 5 Graphs

Record details

Read More Add to Saved list
×
  • 1-10 of  518 results for ""INFLIXIMAB""